Sorrento Therapeutics, Inc.
SRNE
$0.0009
-$0.0001-10.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 31.88% | 37.59% | -149.72% | 59.05% | -435.98% |
| Total Depreciation and Amortization | -0.83% | 8.05% | -0.15% | 3.77% | -1.88% |
| Total Amortization of Deferred Charges | -100.00% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -95.24% | -53.30% | 76,804.96% | -99.89% | 412.59% |
| Change in Net Operating Assets | 9.16% | -29.66% | 74.91% | 336.20% | 223.30% |
| Cash from Operations | -12.54% | 27.63% | -11.72% | 24.47% | 2.85% |
| Capital Expenditure | -62.79% | 98.10% | -17.97% | -41.77% | -4.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 283.39% | -535.72% | 108.82% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 121.28% | -- | -- | -- |
| Cash from Investing | -108.31% | 133.45% | 37.79% | -368.29% | 87.35% |
| Total Debt Issued | 82.39% | 4,615.80% | -97.86% | 148,196.43% | -100.05% |
| Total Debt Repaid | 51.42% | 89.99% | 14.27% | 34.24% | -30.44% |
| Issuance of Common Stock | -- | -63.35% | -12.32% | -31.81% | -36.30% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 45.13% | 144.00% | -64.92% | 71.17% | -75.91% |
| Foreign Exchange rate Adjustments | -253.33% | -51.61% | 165.47% | -207.47% | 44.20% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 128.90% | 129.80% | -13,898.24% | 100.82% | -155.24% |